Cargando…
Chinese and Western Integrative Medicine for Stage IIIb-IVb Non-Small Cell Lung Cancer: Design and Rationale of a Multi-center, Prospective Registry (NSCLC-Chinese and Western Integrative Medicine cohort)
INTRODUCTION: This planned multicenter observational study will evaluate the overall survival of those undergoing integrated Chinese and Western medicine for stage IIIb-IVb non-small cell lung cancer and analyze the factors related to the prognosis. METHOD AND ANALYSIS: The prospective cohort will e...
Autores principales: | Lin, Jietao, Sun, Lingling, Chen, Hanrui, Chen, Wenmin, Zhang, Zexin, Cao, Yang, Lin, Lizhu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10387678/ https://www.ncbi.nlm.nih.gov/pubmed/37493017 http://dx.doi.org/10.1177/15347354231185109 |
Ejemplares similares
-
Zhengyuan capsules for the treatment of chemotherapy-induced cancer-related fatigue in stage IIIB–IV unresectable NSCLC: study protocol for a randomized, multi-center, double-blind, placebo-controlled clinical trial
por: Lin, Jietao, et al.
Publicado: (2022) -
Applying integrative Chinese and western medicine in fighting SARS
por: Lin, Lin, et al.
Publicado: (2003) -
Combating COVID-19 with integrated traditional Chinese and Western medicine in China
por: Ni, Liqiang, et al.
Publicado: (2020) -
Guidelines on the treatment with integrated traditional Chinese medicine and western medicine for severe coronavirus disease 2019
por: Li, Zhi-Yu, et al.
Publicado: (2021) -
Integrative Western and Chinese Medicine on Coronary Heart Disease: Where Is the Orientation?
por: Li, Siming, et al.
Publicado: (2013)